Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Theranostics
ISSN 1838-7640 · Ivyspring International Publisher · AUSTRALIA · Founded 2011
Theranostics: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 14.95; fully open access; APC charged, amount not published; median 114 days to acceptance (99 articles, last 24 months); community-reported acceptance: about 50%; 571 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Theranostics is published by Ivyspring International Publisher and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery and Extracellular vesicles in disease, together about 27.8% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
The aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine community and allied professions involved in the efforts of integrating molecular imaging and molecular therapy. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, point-of-care and personalized medicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editorial board by country: 6 in mainland China (about 14%); most named United States 20, Mainland China 6, Germany 5, South Korea 3, Spain 3 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoplatforms for cancer theranosticsEngineering14%
- Nanoparticle-Based Drug DeliveryMaterials Science7.6%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology6.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.5%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.5%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology4.4%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.1%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 14.95LetPub ·
- Impact factor (publisher)
- 14.9Publisher website ·
- CiteScore 2026-06
- 23.9LetPub ·
- SJR 2026-06
- 3.37LetPub ·
- SNIP 2026-06
- 2.18LetPub ·
- h-index
- 69LetPub ·
- h-index
- 230OpenAlex ·
- i10-index
- 4,629OpenAlex ·
- 2-year mean citedness
- 14.17OpenAlex ·
- Self-citation rate
- 1.3%LetPub ·
- Share of gold OA articles
- 99.92%LetPub ·
Volume
- Articles per year
- 502LetPub ·
- Articles per year (publisher)
- 10Publisher website ·
Articles by year OpenAlex count · 5,608 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 300 | 300 | 439 |
| 2025 | 571 | 571 | 6,046 |
| 2024 | 458 | 458 | 12,342 |
| 2023 | 332 | 332 | 14,575 |
| 2022 | 448 | 448 | 25,926 |
| 2021 | 534 | 534 | 41,765 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
114 daysMedian, submission to acceptance · P25–P75 67 days – 143 days
- Acceptance to online
- median 20 days (99 articles)
- Submission to online
- median 137 days
- Sample
- 99 articles with submission and acceptance dates (1,007 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 4,500 | No | CC BY | |
| OpenAlex | AUD 2,500 | — | — | |
| LetPub | AUD 4,500 | No | — | |
| Publisher website | AUD 5,000 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- AUD 5,000
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Graphical abstract
- Required
- Cover letter
- Required
- Not considered
- case reports
Article types accepted5
- othersResearch paper/ Review/ Short research communication/ Others $AUD 5000 *Length not stated
- research paperResearch paper/ Review/ Short research communication/ Others $AUD 5000 *Length not stated
- reviewResearch paper/ Review/ Short research communication/ Others $AUD 5000 *Length not stated
- review articleA well-written review should provide an authoritative and in-depth understanding of key topics in medicine, offering a high-quality, state-of-the-art account of…Length not stated
- short research communicationResearch paper/ Review/ Short research communication/ Others $AUD 5000 *Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Plagiarism, Preprints
- Authorship Authorship
Each author listed on a manuscript submitted to this journal must adhere to the four authorship criteria set by the International Committee of Medical Journal Editors (ICMJE): Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Competing interests (also known as "conflicts of interest") that may influence the objective presentation of research findings should be disclosed in a paragraph titled "Competing Interests," placed after the Acknowledgments section and before the References. According to the International Committee of Medical Journal Editors, financial relationships—such as employment, consultancies, stock owners…
Source ↗Publisher website ·- Data availability Data Availability
Data availability: deposit large datasets in public repository; smaller datasets as supplementary materials. Model summary
Authors are recommended to deposit large datasets in a public repository. Smaller datasets may be published as supplementary materials. Authors may provide the following: The location and method for accessing the data. If all data are included in the manuscript or supplementary materials, please specify. If the data will be shared upon request, provide detailed contact information. If the data are…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Ethics committee approval required for human/animal research; Declaration of Helsinki compliance. Model summary
Our journals follow the guidelines set by the Committee on Publication Ethics (COPE) for addressing publication ethics issues. For more details, please visit our dedicated Publication Ethics page.
Source ↗Publisher website ·- License & copyright License
Unless otherwise stated in the individual article, articles published on or after June 10, 2019 are distributed under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0), subject to these Terms of Use. Authors retain copyright of their articles. Articles published before June 10, 2019 were generally distributed under the Creative Commons Attribution-NonCommercial 4.0 Internation…
Source ↗Publisher website ·- Peer review Peer Review
Submitted manuscripts are reviewed for originality, significance, adequacy of documentation, composition, and adherence to these guidelines. However, editorial decisions are based not only on the technical merits of the work but also on factors such as priority for publication and relevance to the general readership of Theranostics. All manuscripts are judged in relation to other submissions curre…
Source ↗Publisher website ·- Plagiarism
Zero-tolerance plagiarism policy, including self-plagiarism. Manuscripts screened at all stages. Model summary
Our journal upholds a zero-tolerance policy toward plagiarism, including self-plagiarism. Manuscripts are screened for plagiarism at all stages—before, during, and after publication. Any manuscript found to contain plagiarism will be rejected at any point in the process.
Source ↗Publisher website ·- Preprints
Preprint submissions allowed; authors may post to other preprint servers after acceptance. Model summary
Manuscripts previously posted on preprint servers (e.g., BioRxiv, MedRxiv, ChemRxiv) may be submitted to our journal. Authors can also post their manuscripts to other preprint servers if the manuscripts are accepted by our journal.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ivyspring International Publisher
- Country or region
- AUSTRALIA
- Language
- English
- Founded
- 2011
- ISSN
- 1838-7640
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Theranostics
What CAS zone is Theranostics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Theranostics is in Zone 1 of Medicine, and in Zone 1 of the minor category Medicine, Research & Experimental; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Theranostics?
The latest impact factor listed by LetPub is 14.95; CiteScore 23.9, h-index 230.
How long does peer review take at Theranostics?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 114 days (interquartile range 67–143 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Theranostics?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Suggested reviewers: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Theranostics based?
Of the 44 board members whose country the journal's board page names, 6 (about 14%) are in mainland China; the countries named most often are United States (20), Mainland China (6) and Germany (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Theranostics?
According to LetPub and DOAJ records, Theranostics is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Theranostics open access, and what is the APC?
Theranostics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .